For the current study, it was essential to model untreated strokes, as we aimed to investigate whether L-lactate, through HCA1-activation, could represent a treatment for patients who were not eligible for thrombolysis or thrombectomy. This evidence concerns the gene HCAR1 and stroke disorder.